MD, FACC, FAHA, FHFSA
The Eliot Corday Professor of Cardiovascular Medicine and Science
Interim Chief of Cardiology, UCLA Division of Cardiology
Director, Ahmanson-UCLA Cardiomyopathy Center
Co-Director, UCLA Preventative Cardiology Program
Gregg C. Fonarow, MD, FACC, FAHA, FHFSA is the Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA. He serves as Chief of the UCLA Division of Cardiology, Director of the Ahmanson-UCLA Cardiomyopathy Center, and Co-Director of UCLA’s Preventative Cardiology Program. He attained the rank of Professor of Medicine, Geffen School of Medicine at UCLA in 2003. His research interests center on acute and chronic heart failure, preventative cardiology, quality of care, outcomes, and implementing treatment systems to improve clinical outcome. Dr. Fonarow has published over 1300 research studies and clinical trials in heart failure, disease management, preventative cardiology, and outcomes research. New therapies and management strategies for advanced heart failure and research into the pathophysiology of this disease are conducted at UCLA under his direction. He has also developed and successfully implemented a comprehensive atherosclerosis treatment program at the UCLA Medical Center (Cardiovascular Hospitalization Atherosclerosis Management Program: CHAMP), which served as the model for the American Heart Association’s Get With The Guidelines Program. Dr. Fonarow is a past chair of the steering committee for AHA Get With The Guideline’s Program and the ACC ACTION Registry-GWTG. He also chaired ADHERE, OPTIMIZE-HF, IMPROVE-HF, and CHAMP-HF performance improvement registries. He is on the steering committee and serves as an investigator for a number of ongoing randomized clinical trials in heart failure. Dr Fonarow is immediate past chair of the ACC/AHA Task Force for Performance Measures. He serves as a reviewer and serves on the editorial boards for a number of leading cardiovascular journals. Dr. Fonarow received the outstanding UCLA Cardiology Faculty Teaching Award in 1997 and was honored by the American College of Cardiology with the W. Proctor Harvey Young Teacher Award in 1998. He received an AHA Award of Meritorious Achievement in 2004. In 2009, he received the Raymond D. Bahr Award of Excellence and the Turning Guidelines into Lifelines Award from the AHA. Each year 2014 to 2019, Dr. Fonarow has been selected by Clarivate for the list of Highly Cited Researchers, which identifies the world’s most influential contemporary researchers across 21 scientific fields with the greatest number of published articles that received marks for exceptional impact. In 2015, Dr. Fonarow received a Clinical Research Forum Distinguished Clinical Achievement Award. In 2017, Dr. Fonarow received the Champion of Heart Award from the AHA Western States and the 2017 AHA National Chairman’s Award. In 2019, he received the Outstanding Lifetime Achievement Award from the AHA Quality of Care and Outcomes Research Council.